Clinical trials that successfully reduced anxiety in participants have consistently used oral CBD doses of 300 mg, with some studies showing effects at 400 mg. That’s significantly higher than what most over-the-counter CBD products suggest on their labels, which typically recommend 10 to 50 mg. The gap between what’s sold and what’s been studied is one of the most important things to understand before you spend money on CBD for relaxation.
What Clinical Trials Actually Used
The strongest evidence for CBD’s calming effects comes from studies on public speaking anxiety, a reliably stressful situation researchers use to test anti-anxiety treatments. In multiple trials, 300 mg of oral CBD significantly reduced self-reported anxiety compared to placebo in people asked to give a speech. One study tested three different doses (150 mg, 300 mg, and 600 mg) against placebo and found that only the 300 mg dose worked. The lower dose wasn’t enough, and curiously, the higher dose wasn’t effective either, suggesting CBD’s anxiety-relieving effects may follow an inverted U-shaped curve where more isn’t better.
A four-week trial in Japanese adolescents with social anxiety disorder found that 300 mg daily reduced anxiety symptoms compared to placebo. A separate small trial showed 400 mg reduced subjective anxiety in people with social anxiety disorder. And during the COVID pandemic, roughly 300 mg per day reduced emotional exhaustion and burnout in healthcare workers in open-label trials. So the clinical dose that consistently shows up in successful anxiety research is 300 to 400 mg per day, taken orally.
Why Most Products Suggest Much Less
A typical CBD gummy contains 10 to 25 mg. A full dropper of many CBD oils delivers 15 to 50 mg. At those doses, you’d need to consume an entire bottle in a day to reach the 300 mg threshold used in clinical trials. This doesn’t necessarily mean low doses do nothing. It means that at lower doses, there’s no strong clinical evidence separating CBD from placebo for anxiety relief. Any relaxation you feel at 25 mg could be real, or it could be a placebo response, and the existing research can’t tell you which.
The FDA has not approved any CBD product for anxiety or relaxation, and there are no official dosage guidelines for these uses. The only FDA-approved CBD medication is prescribed for severe epilepsy at doses up to 20 mg per kilogram of body weight, which for an average adult would be well over 1,000 mg daily. That’s a medical context with close monitoring and has little relevance to casual use for stress relief.
How CBD Affects Your Brain
CBD’s calming effects appear to work primarily through serotonin receptors, specifically a subtype called 5-HT1A. This is the same receptor system targeted by some prescription anti-anxiety medications. Animal research has confirmed that when this receptor is blocked, CBD loses its anxiety-reducing properties, while its pain-relieving effects remain. CBD does not work through the same receptors as THC, which is why it doesn’t produce a high. It has very low affinity for the cannabinoid receptors that THC activates.
Your Body Absorbs Less Than You Think
One reason the effective dose is so high is that CBD is poorly absorbed when swallowed. Oral bioavailability sits around 6%, meaning if you take a 50 mg gummy, your body may only use about 3 mg of actual CBD. The rest is broken down by your liver and digestive system before it reaches your bloodstream. It also takes one to four hours to feel anything from an oral dose, so don’t expect immediate effects from gummies or capsules.
Inhaled CBD (through vaping) has dramatically higher bioavailability, averaging 31% with a range of 11 to 45%. Peak levels hit within about three minutes. That faster delivery and higher absorption rate means a much smaller inhaled dose could theoretically match the blood levels of a much larger oral dose. However, most clinical anxiety trials used oral dosing, so the 300 mg figure applies specifically to swallowed CBD. And vaping carries its own set of lung health concerns unrelated to CBD itself.
Sublingual drops (held under the tongue) are marketed as a middle ground. They bypass some first-pass liver metabolism by absorbing through the tissue under your tongue, though precise bioavailability numbers for sublingual CBD are less well-established in published research than oral and inhaled routes.
Full-Spectrum, Broad-Spectrum, or Isolate
CBD products come in three types. Full-spectrum contains all compounds from the cannabis plant, including trace THC (under 0.3%). Broad-spectrum includes most plant compounds with minimal THC. CBD isolate is pure CBD with nothing else. The “entourage effect” theory suggests that full-spectrum products work better because the various plant compounds enhance each other. There is some preliminary evidence supporting this, but a 2023 review found little solid scientific backing for the theory. Most clinical anxiety trials used pure CBD isolate, so the 300 mg benchmark comes from isolate research. Whether full-spectrum products could achieve similar effects at lower doses remains unproven.
Factors That Shift Your Response
Individual responses to CBD vary enormously. Clinicians who work with cannabis-based treatments report effective doses ranging from as little as 1 mg to over 2,000 mg daily across different patients and conditions. Your response depends on your overall health, genetics, body composition, stress levels, sleep patterns, and what’s sometimes called “endocannabinoid tone,” essentially how active your body’s own cannabinoid system already is. There’s no reliable formula based on body weight for relaxation purposes, though some practitioners use 1 mg per kilogram of body weight as a starting point for other conditions.
Side Effects and Safety Limits
At doses used in clinical trials, the most common side effects are drowsiness, fatigue, and lethargy. Some people experience diarrhea or changes in appetite. At very high doses used in epilepsy treatment, liver enzyme elevations have been documented, though serious liver injury is rare. In animal studies, more concerning effects like organ changes and reduced fertility appeared at doses above 200 mg per kilogram per day, far beyond anything used in human relaxation contexts.
The more pressing safety concern is drug interactions. CBD inhibits several liver enzymes responsible for processing common medications. If you take antidepressants (SSRIs, tricyclics, or MAOIs), blood thinners like warfarin, anti-seizure medications, beta-blockers, opioid pain medications, or immunosuppressants, CBD can increase the levels of these drugs in your blood, sometimes significantly. One case study documented a patient who needed a 30% reduction in their warfarin dose after starting CBD. Another found a threefold increase in tacrolimus concentrations. If you take any prescription medication, this interaction risk is not trivial.
A Practical Starting Point
Given the research, here’s what the evidence actually supports. For clinically meaningful anxiety reduction, the studied dose is 300 mg of oral CBD. Most people experimenting with CBD for relaxation start far lower and may or may not notice effects. If you want to try CBD, starting low (25 to 50 mg) and gradually increasing gives you a chance to gauge your individual tolerance and watch for side effects like excessive drowsiness. Keep in mind that with 6% oral bioavailability, the amount reaching your system is a fraction of what’s on the label.
The CBD market is largely unregulated, and independent testing has repeatedly found that products contain more or less CBD than labeled, sometimes with undisclosed THC. Look for products with third-party lab testing (often called a certificate of analysis) that verifies cannabinoid content and screens for contaminants. Without that, you can’t be confident you’re taking the dose you think you are.